Skip to content

Observational study to find out the result of various Ayurveda treatment methods used for the managment of Rheumatoid Arthritis.

An Observational study to explore the outcome of multimodal Ayurveda treatment in the management of Rheumatoid Arthritis a Prospective Cohort study. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/075805
Enrollment
70
Registered
2024-10-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patient fulfilling Diagnostic Criteria 2010 ACR (American College of Rheumatology) /EULAR (European League Against Rheumatism) criteria for RA (min. 6/10). Raised level in one of the following biochemical Investigations RA Factor,CRP,Anti CCP,ESR , Serum Uric Acid. Patients having classical signs and symptoms of Amavatah & Vatarakta.

Exclusion criteria

Exclusion criteria: Patients having severe illness CAD ,respiratory failure, stroke etc. Patients suffering from pre-existing systemic illnesses- CAD, uncontrolled diabetes mellitus and Hypertension , CKD, Cirrhosis, malignancies- that may jeopardise the treatment outcomes. Patients taking DMARDs and Biologicals during the intervention period. Patients having co-existing Autoimmune conditions – SLE, Spondyloarthropathy, scleroderma . Pregnant women and lactating mother.

Design outcomes

Primary

MeasureTime frame
Observing, analyse and documenting Change in CRP , ESR , RA Factor , NLR ,Uric Acid levels along with change in other objective parameters DAS28 SCORE,CDAI. Observe the Change in Clinical symptomatology of the RA patients. Timepoint: Day 0 Day 15 Day 30 Day 45 Day 60 Day 120

Secondary

MeasureTime frame
Observing Change in Qualty of Life of RA affected individuals.Timepoint: Day 0 Day 15 Day 30 Day 45 Day 60 Day 120

Countries

India

Contacts

Public ContactDr VG Huddar

All India Institute of Ayurveda

drvghuddar@gmail.com9986697942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026